hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia

被引：0
|
作者：
Islem Ben Hassine
Hanene Gharbi
Ismail Soltani
Mouheb Teber
Ahlem Farrah
Hind Ben Hadj Othman
Hassiba Amouri
Hatem Bellaaj
Rayhane Ben lakhal
Neila Ben Romdhane
Salem Abbes
Samia Menif
机构：
[1] University of Tunis El Manar,Laboratory of Molecular and Cellular Hematology, Pasteur Institute of Tunis
[2] Faculté de médicine de Tunis,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 79卷
关键词：
Chronic myeloid leukemia; Imatinib mesylate; Resistance; hOCT1; Expression; Polymorphisms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：737 / 745
页数：8
相关论文
共 50 条
  • [1] hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia
    Ben Hassine, Islem
    Gharbi, Hanene
    Soltani, Ismail
    Teber, Mouheb
    Farrah, Ahlem
    Othman, Hind Ben Hadj
    Amouri, Hassiba
    Bellaaj, Hatem
    Ben lakhal, Rayhane
    Ben Romdhane, Neila
    Abbes, Salem
    Menif, Samia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (04) : 737 - 745
  • [2] Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia
    Nardinelli, Luciana
    Sanabani, Sabri Saeed
    Didone, Alline
    Ferreira, Patricia de Barros
    Serpa, Mariana
    Yoshinaga Novaes, Mafalda Megumi
    Marchiani, Mariana
    Ruiz, Antonio Lancha
    Lima, Ismael Severino
    Fischer Chamone, Dalton de Alencar
    Bendit, Israel
    ACTA HAEMATOLOGICA, 2012, 127 (04) : 228 - 234
  • [3] hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia
    Bazeos, A.
    Marin, D.
    Reid, A. G.
    Gerrard, G.
    Milojkovic, D.
    May, P. C.
    de Lavallade, H.
    Garland, P.
    Rezvani, K.
    Apperley, J. F.
    Goldman, J. M.
    Foroni, L.
    Khorashad, J. S.
    LEUKEMIA, 2010, 24 (06) : 1243 - 1245
  • [4] Genetic variations of hOCT1 gene and CYP3A4/A5 genes and their association with imatinib response in Chronic Myeloid Leukemia
    Vaidya, Shantashri
    Ghosh, Kanjaksha
    Shanmukhaiah, Chandrakala
    Vundinti, Babu Rao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 124 - 130
  • [5] The c.480C > G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia
    Di Paolo, A.
    Polillo, M.
    Capecchi, M.
    Cervetti, G.
    Barate, C.
    Angelini, S.
    Guerrini, F.
    Fontanelli, G.
    Arici, R.
    Ciabatti, E.
    Grassi, S.
    Bocci, G.
    Hrelia, P.
    Danesi, R.
    Petrini, M.
    Galimberti, S.
    PHARMACOGENOMICS JOURNAL, 2014, 14 (04) : 328 - 335
  • [6] The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia
    A Di Paolo
    M Polillo
    M Capecchi
    G Cervetti
    C Baratè
    S Angelini
    F Guerrini
    G Fontanelli
    R Arici
    E Ciabatti
    S Grassi
    G Bocci
    P Hrelia
    R Danesi
    M Petrini
    S Galimberti
    The Pharmacogenomics Journal, 2014, 14 : 328 - 335
  • [7] Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia
    Maffioli, Margherita
    Camos, Mireia
    Gaya, Anna
    Hernandez-Boluda, Juan-Carlos
    Alvarez-Larran, Alberto
    Domingo, Abel
    Granell, Miquel
    Guillem, Vicent
    Vallansot, Rolando
    Costa, Dolors
    Bellosillo, Beatriz
    Colomer, Dolors
    Cervantes, Francisco
    LEUKEMIA RESEARCH, 2011, 35 (08) : 1014 - 1019
  • [8] Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia
    Ben Hassine, Islem
    Gharbi, Hanene
    Soltani, Ismail
    Othman, Hind Ben Hadj
    Farrah, Ahlem
    Amouri, Hassiba
    Teber, Mouheb
    Ghedira, Hela
    Ben Youssef, Yosra
    Safra, Ines
    Abbes, Salem
    Menif, Samia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (04) : 829 - 839
  • [9] Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia
    Islem Ben Hassine
    Hanene Gharbi
    Ismail Soltani
    Hind Ben Hadj Othman
    Ahlem Farrah
    Hassiba Amouri
    Mouheb Teber
    Hela Ghedira
    Yosra Ben Youssef
    Ines Safra
    Salem Abbes
    Samia Menif
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 829 - 839
  • [10] Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance
    Soltani, Ismael
    Douzi, Kais
    Gharbi, Hanen
    Benhassine, Islem
    Teber, Mouheb
    Amouri, Hassiba
    Othman, Hind Ben Hadj
    Farrah, Ahlem
    Ben Lakhel, Raihane
    Abbes, Salem
    Menif, Samia
    HEMATOLOGY, 2017, 22 (04) : 201 - 207
12345